image
Healthcare - Biotechnology - NASDAQ - US
$ 0.1901
-2.51 %
$ 40.2 M
Market Cap
None
P/E
BALANCE SHEET
18.9 M ASSETS
-39.74%
6.61 M LIABILITIES
143.13%
12.3 M EQUITY
-57.07%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition Reviva Pharmaceuticals Holdings, Inc.
image
Current Assets 18.9 M
Cash & Short-Term Investments 18.5 M
Receivables 0
Other Current Assets 404 K
Non-Current Assets 0
Long-Term Investments 0
PP&E 0
Other Non-Current Assets 0
Current Liabilities 6.04 M
Accounts Payable 3.52 M
Short-Term Debt 0
Other Current Liabilities 2.52 M
Non-Current Liabilities 567 K
Long-Term Debt 0
Other Non-Current Liabilities 567 K

Balance Sheet

Millions
Dec-2022 Dec-2021 Dec-2020 Feb-2020
ASSETS
Cash & Cash Equivalents 18.5 29.7 8.8 193
Short Term Investments 0 0 0 65.2
Receivables 0 0 0 0
Inventory 0 0 0 0
Other Current Assets 0.4 1.7 69.6 K 0
Total Current Assets 18.9 31.4 8.8 193
PP&E 0 0 0 591
Intangible Assets 0 0 0 0
Goodwill 0 0 0 0
Long Term Investments 0 0 0 0
Other Long Term Assets 0 0 1.82 K 1.82 K
Other Assets 0.4 1.7 0 0
Total Assets 18.9 31.4 8.8 2.6 K
LIABILITIES
Accounts Payable 3.5 0.5 1.0 0.2
Short Term Debt 0 0 0 3.8
Other Current Liabilities (1.0) 1.3 (0.7) (0.1)
Total Current Liabilities 6.0 2.3 1.3 6.8
Long Term Debt 0 0 0 0
Deferred Tax Income 0 0 0 0
Other Liabilities 0.6 0.4 3.0 0
Total Liabilities 6.6 2.7 1.3 6.8
EQUITY
Common Stock 2.04 K 1.44 K 923 618
Retained Earnings (91.2) (66.8) (58.3) (54.5)
Other Accumulative Comprehensive Income/Loss 0 0 0 (54.5)
Total Equity 12.3 28.7 7.4 (6.8)
Total Liabilities and Equity 18.9 31.4 8.8 2.6 K
SHARES OUTSTANDING
Common Shares Outstanding 19.5 14.8 3.1 2.8